| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/13/2008 | US7371846 Chemokine coreceptor fusion for use prevention and treatment of viral infection; immunotherapy |
| 05/13/2008 | US7371834 Apoptosis-inducing factor |
| 05/13/2008 | US7371833 Nucleic acid molecules with specific recognition of native PrPSc, production and use |
| 05/13/2008 | US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371813 Method for use of IGF-binding protein for selective sensitization of target cells in vivo |
| 05/13/2008 | US7371780 For combination with taxanes and anthracyclines; photodynamic therapy; for uterine/breast cancer |
| 05/13/2008 | US7371779 Synergistic compositions of N-acylhomoserine lactones and 4-quinolones |
| 05/13/2008 | US7371778 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371776 Methods and compositions for treating cancer |
| 05/13/2008 | US7371775 nonhydroscopic, suitable for preparation of metered dose of 7-carboxymethyloxy-3',4',5-trimethoxy flavone (mucus protecting activity for gastrointestinal tract); storage stability; methylation of 3',5,7-trihydroxy-4'-methoxy flavone-7-rutinoside, followed by acetylation and deprotection |
| 05/13/2008 | US7371774 Benzofurans and benzothiophenes |
| 05/13/2008 | US7371773 2-(3,4-dimethoxy-phenyl)-3-(4-hydroxy-phenyl)-acrylonitrile; drug transporter, which actively transports an anticancer drug out of cancer cells, antagonist; improve drug resistance; anticarcinogenic agent; enhance bioavailability of anticancer drug |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/13/2008 | US7371771 Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase |
| 05/13/2008 | US7371770 Acylaminothiazole derivatives and use thereof as β-amyloid inhibitors |
| 05/13/2008 | US7371769 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| 05/13/2008 | US7371767 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 05/13/2008 | US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371763 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 05/13/2008 | US7371762 Infections caused by Gram positive and/or negative pathogens |
| 05/13/2008 | US7371761 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/13/2008 | US7371759 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents |
| 05/13/2008 | US7371757 Fused heterocycles as inhibitors of glutamate racemase(MURI) |
| 05/13/2008 | US7371756 Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/13/2008 | US7371755 Antiviral agents |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | US7371752 such as 5-(4-Fluorophenyl)-7-[(2-pyridyl)-methyloxy]-thieno[3,2-b]pyridine, used as prodrugs or antagonists for GABA receptors, in diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and epileptic disorders, as cognition activators and as antidotes to benzodiazepines |
| 05/13/2008 | US7371751 2,4-dichloro-N-(4-chloro-3-methoxy-phenyl)-N-[4-(pyrrolidine-1-carbonyl)thiazole-2-yl]-benzamide; cannabionic receptor (CB1) antagonist and inverse agonists; side effects reduction; amidation of aminothiazol derivatives with acid chloride and coupling by dehydroxylation with alcohol or amine derivatives |
| 05/13/2008 | US7371750 Compounds and compositions as protein kinase inhibitors |
| 05/13/2008 | US7371749 Benzothiazole derivatives |
| 05/13/2008 | US7371748 Benzothiazole derivatives |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371745 Bis-transition-metal-chelate probes |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371743 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/13/2008 | US7371742 Destroying tumor, viruses, bacteria cells ; retinoblastmas therapy |
| 05/13/2008 | US7371741 Angiogenesis inhibitor |
| 05/13/2008 | US7371740 Phosphorylated glyceryl ether aluminum salt |
| 05/13/2008 | US7371739 Aryl fructose-1,6-bisphosphatase inhibitors |
| 05/13/2008 | US7371737 E.g., 2-nitro-6-trifluoromethyl-9-methyl purine; 2-morpholinyl-6-fluoromethyl-9- beta -D-ribofuranosyl purine; 6-trifluoromethyl-9-methyl-2-benzylamino purine; intermediates; preparation |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371734 Oligonucleotide compositions and their use for the modulation of immune responses |
| 05/13/2008 | US7371733 Paranmycin antibiotics with activity against resistant bacterial strains equipped with aminoglycoside modifying enzymes. |
| 05/13/2008 | US7371732 for inhibiting the sodium-dependent glucose cotransporter; 1-( beta -D-glucopyranosyloxy)-2-[4-((R)-tetrahydrofuran-3-yloxy)benzyl]-benzene, 1-( beta -D-glucopyranosyloxy)-2-(4-ethynylbenzyl)-benzene |
| 05/13/2008 | US7371731 ADMINISTERING GLUCOSE PENTASULFATE FOR THERAPY OF amyloid disease |
| 05/13/2008 | US7371730 Crystals of glucopyranosyloxybenzyl benzene derivative |
| 05/13/2008 | US7371729 Boronic acid salts useful in parenteral formulations |
| 05/13/2008 | US7371585 Membranes incorporating recognition moieties |
| 05/13/2008 | US7371548 Expression vector comprising nucleotide sequences coding enzymatic polypeptide associated with polyketide biosynthesis for use in identifying modulators of immune response and cell proliferative disorders and which prevent propagation of insects, fungi and parasites |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371415 Method and composition for improving sexual fitness |
| 05/13/2008 | US7371414 Reducing activity of mutant of human cytochrome enzyme; Administering to individual in need of nicotine replacement therapy therapeutically effective amount of nicotine and methoxsalen, to enhance effectiveness |
| 05/13/2008 | US7371407 the oil is used as a carrying agent for anti-microbial formulations; comprises terbinafine and other antibiotics; for topical application to the skin or mucosal membranes of a mammal |
| 05/13/2008 | US7371406 for needles comprising time release microparticles containing risperidones, glycolic acid-lactic acid copolymer binders, and high viscosity aqueous fluids (containing sodium carboxymethyl cellulose as modifier) |
| 05/13/2008 | US7371404 Amphoteric liposomes and their use |
| 05/13/2008 | US7371396 Dermatological and cosmetic compositions |
| 05/13/2008 | US7371385 Method of treating immune pathologies with low dose estrogen |
| 05/13/2008 | US7371379 Epidermal growth factors (ErbB2); gene expression inhibition; anticancer agents |
| 05/13/2008 | US7371372 Inosine monophosphate dehydrogenase inhibitor and interferon; hepatitis C |
| 05/13/2008 | US7371369 Polymeric interpenetrated network carrier and serial polymerization involving a crosslinked polymer network |
| 05/13/2008 | US7371069 Manikin and eye device apparatus, methods and articles of manufacture |
| 05/13/2008 | CA2469343C Combination of cytochome p450 dependent protease inhibitors |
| 05/13/2008 | CA2468449C Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 05/13/2008 | CA2438169C Modulated release particles for aerosol delivery |
| 05/13/2008 | CA2434790C Method for isolating pharmaceutically exploitable etidronate disodium |
| 05/13/2008 | CA2410234C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 05/13/2008 | CA2409292C Tablets and methods for modified release of hydrophilic and other active agents |
| 05/13/2008 | CA2378490C Antibiotic/antibiotics (or: antibiotic(s)) preparation with retarding active ingredient release |
| 05/13/2008 | CA2327395C New imidazotriazolopyrimidines, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | CA2324953C Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 05/13/2008 | CA2323414C Cytostatic agents |
| 05/13/2008 | CA2322847C Steroid derived antibiotics |
| 05/13/2008 | CA2310222C New composition of matter |
| 05/13/2008 | CA2299909C Therapeutic agent for neurodegenerative disorders |
| 05/13/2008 | CA2293470C Benzimidazole derivatives |
| 05/13/2008 | CA2279939C Treatment and prevention of adhesions |
| 05/13/2008 | CA2263348C Pharmaceutical composition containing 4-oxo-butynic acids |
| 05/13/2008 | CA2259780C Alcohol based anti-microbial compositions with cosmetic appearance |
| 05/13/2008 | CA2259012C S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| 05/13/2008 | CA2255856C Therapeutic uses for an aminosterol compound |
| 05/13/2008 | CA2250919C Photopheresis treatment of leukocytes |
| 05/13/2008 | CA2235298C Isoxazole derivatives |
| 05/13/2008 | CA2234284C Solid biologically active silicon-based compounds |
| 05/13/2008 | CA2214894C Substituted dibenz[a,f]azulenes and methods of preparation |
| 05/13/2008 | CA2213322C Thiols to promote hematopoietic progenitor cell growth |
| 05/13/2008 | CA2212058C Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease |
| 05/13/2008 | CA2206119C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 05/13/2008 | CA2196995C Spiro-azabicyclic compounds useful in therapy |
| 05/13/2008 | CA2184916C Use of fibroblast growth factors to stimulate bone growth |
| 05/13/2008 | CA2125855C A stabilized pharmaceutical formulation comprising growth hormone and histidine |
| 05/10/2008 | CA2567621A1 Herbal product comprising cinnamon, bitter melon and omega-3 fatty acids |
| 05/08/2008 | WO2008055261A2 Therapeutic compounds |
| 05/08/2008 | WO2008055233A1 Protein kinase inhibitors |
| 05/08/2008 | WO2008055022A2 Carbamate compounds for use in treating depression |
| 05/08/2008 | WO2008055013A2 5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase |
| 05/08/2008 | WO2008054984A1 Treatment of pervasive developmental disorders |